Yuval Avni,
M.D., CEO

Yuval Avni, M.D., CEO

Prior to joining Beta-O2 Technologies, Ltd, Dr. Avni was a partner at Giza VC, a leading early stage Israeli venture capital firm with more than $600M under management. With a focus on the life science and clean tech sectors. Dr. Avni was involved in the entire investment process – sourcing, screening and due diligence. He led or co-led investments in many technology companies, supporting them from investment through exit. Dr. Avni also led Giza’s international business development group and was part of the founding team of the firm’s sponsored VC funds worldwide.

In addition to vast experience as a venture capitalist, Dr. Avni is also a trained physician, with clinical experience in general and vascular surgery. He has conducted clinical research in the areas of human genetics, general surgery and vascular surgery.

Dr. Avni is a visiting lecturer on entrepreneurship and fundraising at the Technion Israel Institute of Technology and Tel University. He is also a consultant on entrepreneurship at ORT Israel, a premier technology school network as well as at the Tel Aviv University Entrepreneurship Center (StarTAU) and Technion For Life, the Technion alumni entrepreneurship program.

Dr. Avni served for five years in the Israel Defense Forces as an officer in an elite intelligence unit. Following medical training, he joined the airborne rescue and evacuation unit of the Israel Air Force, where he continues to serve as a physician in the active reserves until today. Dr. Avni also consults on new technologies for the IAF chief medical officer.

Dr. Avni received his medical training at the Technion and holds a Bachelor’s degree (with honors) from the Technion in medical science.

Meet the other team members

Clef two-factor authentication